Search
for

    Sort by

    Research 91–120 of 437

    1. Localized Epidermolysis Bullosa Simplex (Weber-Cockayne type) Journal of Pediatric and Adolescent Gynecology · 2011
    2. Subject Index Journal of the American Academy of Dermatology · 2009
    3. Penile vascular abnormalities in young men with persistent side effects after finasteride use for the treatment of androgenic alopecia Translational Andrology and Urology · 2020 · 7 citations
    4. Are finasteride-related penile curvature/Peyronie’s disease Adverse Event Reports worthy of further clinical investigation? Disproportionality analysis based on both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases International Journal of Impotence Research · 2022 · 2 citations
    5. The Effects of Oral 5-alpha Reductase Inhibitors on Penile Intracavernosal Pressures and Penile Morphology in Rat Model. PubMed · 2019 · 2 citations
    6. Effects of pre- and post-pubertal dihydrotestosterone treatment on penile length in 5α-reductase type 2 deficiency Endocrine journal · 2019 · 13 citations
    7. 311 Novel Penile Ultrasound Technique to Explain Mechanism of Erectile Dysfunction (ED) in Young Patients using Finasteride for Androgenic Alopecia The Journal of Sexual Medicine · 2018 · 1 citations
    8. 133 Grey-Scale Penile Ultrasound Findings in Young Men with Erectile Dysfunction (ED) Who Used Finasteride for Androgenic Alopecia: A Retrospective Review The Journal of Sexual Medicine · 2017
    9. 424 Grey-Scale Penile Ultrasound Findings in Young Men With Erectile Dysfunction (ED) Who Used Finasteride for Androgenic Alopecia The Journal of Sexual Medicine · 2016
    10. Is finasteride intake associated with penile curvature/peyronie’s disease? Assessment of both the food and drug administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases European urology open science · 2021
    11. Effects of androgen on extracellular vesicles from endothelial cells in rat penile corpus cavernosum Andrology · 2021 · 3 citations
    12. Evaluation of BMI as a Risk Factor for Complications following Gender-affirming Penile Inversion Vaginoplasty Plastic and Reconstructive Surgery – Global Open · 2019 · 23 citations
    13. Organic Causes of Erectile Dysfunction in Men Under 40 Urologia Internationalis · 2013 · 2152 citations
    14. Critical Developmental Periods for Effects on Male Rat Genitalia Induced by Finasteride, a 5α-Reductase Inhibitor Toxicology and Applied Pharmacology · 1993 · 86 citations
    15. Specific morphogenetic events in mouse external genitalia sex differentiation are responsive/dependent upon androgens and/or estrogens Differentiation · 2012 · 51 citations
    16. An observational retrospective evaluation of 79 young men with long-term adverse effects after use of finasteride against androgenetic alopecia International Journal of Andrology · 2016 · 43 citations
    17. Long-term Oral Administration of 5α-reductase Inhibitor Attenuates Erectile Function by Inhibiting Autophagy and Promoting Apoptosis of Smooth Muscle Cells in Corpus Cavernosum of Aged Rats Urology · 2013 · 34 citations
    18. Hormone-dependent medial preoptic/lumbar spinal cord/autonomic coordination supporting male sexual behaviors Molecular and cellular endocrinology · 2017 · 28 citations
    19. Morphological Features of External Genitalia in Hypospadiac Rat Model: 3-Dimensional Analysis The Journal of Urology · 2004 · 18 citations
    20. The corpus cavernosum after treatment with dutasteride or finasteride: A histomorphometric study in a benign prostatic hyperplasia rodent model Asian Journal of Andrology · 2018 · 11 citations
    21. Exploring the efficacy of testosterone undecanoate in male children with 5α‐reductase deficiency Pediatric investigation · 2021 · 5 citations
    22. Trimodal mini-invasive therapy for stable-phase Peyronie's disease: a two-center real-life prospective pilot study 2025
    23. Insights into the Scenario of SARS-CoV-2 Infection in Male Reproductive Toxicity Vaccines · 2023
    24. Longitudinal clinical course in patients with 5α-reductase type 2 deficiency treated with testosterone and dihydrotestosterone during infancy and puberty Endocrine journal · 2022
    25. A proposed etiopathology of persistent dysfunctions emerging from use and discontinuation of 5-alpha reductase inhibitors: sequelae of drug-mediated microvasculopathy 2022
    26. HP-01-004 Histomorphometrical Evaluation of The Corpus Cavernosum of Hypertensive Rats Treated with 5-Alpha-Reductase Inhibitors ˜The œjournal of sexual medicine · 2017
    27. MP45-10 HISTOMORPHOMETRICAL EVALUATION OF THE CORPUS CAVERNOSUM OF HYPERTENSIVE RATS TREATED WITH 5-?-REDUCTASE INHIBITORS 2017
    28. MP45-12 CHRONIC ADMINISTRATION OF A LIMK2 INHIBITOR IMPROVES CAVERNOSAL VENO-OCCLUSIVE DYSFUNCTION THROUGH SUPPRESSION OF CAVERNOSAL FIBROSIS IN A RAT MODEL OF ERECTILE DYSFUNCTION AFTER CAVERNOSAL NERVE INJURY 2017
    29. Urological Oncology: Testis Cancer and Advances in Oncological Therapy The Journal of Urology · 2007
    30. 124 The Persistent Effects of 5α-reductase Inhibitors Used in the Treatment of Androgenic Alopecia on Men’s Health The Journal of Sexual Medicine · 2020